<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-pharmaceutics-12-00138">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sonvico</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Clementino</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Buttini</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Colombo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Pescina</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Stanis√ßuaski Guterres</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Raffin Pohlmann</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nicoli</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting</article-title>
  <source>Pharmaceutics</source>
  <year>2018</year>
  <volume>10</volume>
  <elocation-id>34</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics10010034</pub-id>
  <?supplied-pmid 29543755?>
  <pub-id pub-id-type="pmid">29543755</pub-id>
 </element-citation>
</ref>
